2m 2m 2m 2m 2m 2m 2m
PACS GROUP (PACS)
NYSE
$37.37-$0.41 (-1.07%)
Price as of Jun 23, 2026 7:09 PM EDT- $6.0BMarket Cap
- 196.24%1-Year Change
- Medical Care FacilitiesIndustry
PACS GROUP (PACS)
$37.37-$0.41 (-1.07%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | ||
|---|---|---|---|
Income Statement | |||
Total Operating Revenue | 5.3B +29.32% | 4.1B N/A | |
Cost of Revenue | 4.1B +25.25% | 3.3B N/A | |
Gross Profit | 1.2B +46.25% | 792.6M N/A | |
Sales and Marketing Expense | 11.2M +47.14% | 7.6M N/A | |
Research and Development Expense | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 55.7M +36.40% | 40.8M N/A | |
Total Operating Expenses | 5.0B +25.53% | 4.0B N/A | |
Operating Profit | 309.6M +151.55% | 123.1M N/A | |
Interest Income | N/A N/A | N/A N/A | |
Interest Expense | -129,000 +35.79% | -95,000 N/A | |
Interest Income and Expense and Net | -129,000 +35.79% | -95,000 N/A | |
Total Nonoperating Income and Expense | -25.1M +16.85% | -21.5M N/A | |
Income before Taxes | 284.4M +413.97% | 55.3M N/A | |
Income Taxes | 93.0M +309.04% | -44.5M N/A | |
Extraordinary Items | N/A N/A | N/A N/A | |
Net Income | 191.5M +246.10% | 55.3M N/A | |
Net Income from Continuing Operations Applicable to Common | 284.4M +413.97% | 55.3M N/A | |
Basic EPS and Net Income | 1.23 +223.68% | 0.38 N/A | |
Diluted EPS and Net Income | 1.22 +221.05% | 0.38 N/A | |
Basic Weighted Average Shares | 156.2M +6.49% | 146.7M N/A | |
Diluted Weighted Average Shares | 156.7M +5.47% | 148.6M N/A | |
Balance Sheet | |||
Cash and Cash Equivalents | 197.0M +24.95% | 157.7M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 197.0M +24.95% | 157.7M N/A | |
Total Current Assets | 1.1B +14.01% | 938.3M N/A | |
Accumulated Depreciation | 154.2M +45.83% | 105.7M N/A | |
Property and Plant and Equipment and Net | 1.2B +21.25% | 990.6M N/A | |
Total Long-Term Assets | 171.4M +6.37% | 161.1M N/A | |
Total Assets | 5.6B +6.51% | 5.2B N/A | |
Income Taxes Payable | N/A N/A | N/A N/A | |
Total Short-Term Debt | 4.5M -97.15% | 156.9M N/A | |
Total Current Liabilities | 1.0B +2.35% | 978.4M N/A | |
Total Long-Term Debt | 344.8M +37.38% | 251.0M N/A | |
Total Long-Term Liabilities | 152.9M -22.39% | 197.1M N/A | |
Total Liabilities | 4.6B +2.31% | 4.5B N/A | |
Retained Earnings | 309.6M +162.28% | 118.0M N/A | |
Total Stockholders Equity | 946.8M +33.43% | 709.6M N/A | |
Total Shares Outstanding | 156.6M +0.93% | 155.2M N/A | |
Cash Flow | |||
Cash from Operating Activities | 404.2M +10.04% | 367.3M N/A | |
Capital Expenditures | N/A N/A | 1.2M N/A | |
Cash from Investing Activities | -264.0M -40.36% | -442.7M N/A | |
Dividends Paid | 0 -100.00% | 33.7M N/A | |
Cash from Financing Activities | -69.0M -158.73% | 117.5M N/A | |
Financials Ratio | |||
Gross Margin | 21.92% N/A | N/A N/A | |
Operating Margin | 5.85% N/A | N/A N/A | |
Return on Assets | 3.54% N/A | N/A N/A | |
Return on Equity | 23.13% N/A | N/A N/A | |
Revenue Growth | 29.32% N/A | N/A N/A | |
Current Ratio | 1.07 N/A | N/A N/A | |
Cash Ratio | 0.20 N/A | N/A N/A | |
Debt-to-Equity Ratio | 0.37 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.06 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow